Law and the Global Health Crisis

Spring 2015

Professors Fisher & Wu

 

Introduction (February 3, Hauser 103)

Seminar Leader: Rachel Sachs

Readings:

• Fisher & Syed, Infection, Introduction (2015)
• Council on Foreign Relations, "Noncommunicable Diseases in Low- and Middle-Income Countries," Executive Summary (2014)
• Access to Medicine Index (2014)
• Julio Frenk & Suerie Moon, "Governance Challenges in Global Health" (2013)
• Jerome Reichman, "Compulsory Licensing of Patented Pharmaceutical Inventions" (2009)

The Roles of Developed-Country Governments (February 10, Hauser 103)

Seminar Leader: Quentin Palfrey

Readings:

• US Global Development Policy
• Harnessing Innovation for Global Development
• Patents for Humanity
• Priority Review Vouchers
• GRIN-Global Project
• WIPO Re:search
• USAID Grand Challenges for Development
• DARPA Grand Challenge
• Accelerating Access to Innovation and Saving Children’s Lives

The Roles of NGOs (February 24, Hauser 103)

Seminar Leader: John Stubbs

Readings:

• Donald G. McNeil, Jr., Selling Cheap Generid Drugs, India's Copycats Irk Industry
• Indian Company Offers to Supply AIDS Drugs at Low Cost in Africa
• WTO, Doha Declaration Explained
• WHO, Access to Medicines: Intellectual property protection, impact on public health
• Amy Kapczynski, The Access to Knowledge Mobilization and the New Politics of Intellectual Property
• Peter Maybarduk, The Global Access to Medicines Movement: A Brief History and a Case Study
• Alan Sheppard, Generic Medicines: Essential Contributors to the Long-Term Health of Society
• WIPO, The Medicines Patent Pool: Stimulating Innovation, Improving Access
  
  

The Roles of Pharmaceutical Firms (March 10, Hauser 103)

Guest: Jeffrey Kindler

Readings:

• Gilead Announces Generic Licensing Agreements to Increase Access to Hepatitis C Treatments in Developing Countries (2014)
• Phil Taylor, "Sovaldi Deal for Developing World Falls Short" (September 16, 2014)
• Sarah Frew et al., "A Business Plan to Help the 'Global South' in its Fight Against Neglected Diseases," Health Affairs (2009)
• "Novartis' Coartem and the Malaria Initiative" (GAiA Case Study 2014)

The Roles of Developing-Country Governments (March 24, Hauser 103)

Seminar Leader: Mark Wu

Readings:

• Session 5 Overview
• G. Lagomarsino et al., Moving Towards Universal Health Coverage: Health Insurance Reforms in Nine Developing Countries in Africa and Asia, Lancet, Sept. 8, 2012
• IMS Institute, Understanding the Pharmaceutical Value Chain, Nov. 2014
• WHO, Access to Affordable Essential Medicines
• WHO, Guidelines on Country Pharmaceutical Pricing Policies
• How Sick are the World’s Healthcare Systems? The Guardian, Oct. 29, 2014 (read through Egypt only)
• Adam Nossiter, Sierra Leone’s Health Care System Becomes a Cautionary Tale for Donors, N.Y. Times, Apr. 13, 2013
• Olga Kazan, What the U.S. Can Learn From Brazil’s Healthcare Mess, The Atlantic, May 8, 2014
• Peter Ubel, The True Cost of Low Drug Prices, Forbes, Jan. 5, 2015
• Physician, Heal Thyself, Economist, Feb. 1, 2014

What Responsibility do We Bear? (April 7, Hauser 103)

Seminar Leader: William Fisher

Readings:

• Chris Beyer et al., "Neglected Diseases, Civil Conflict, and the Right to Health," The Lancet 370 (2007): 619-27
• Jorn Sonderholm, "A Reform Proposal in Need of Reform," 3 Public Health Ethics (2010): 167-77
• Thomas Pogge et al., "A Critique in Need of Critique," 3 Public Health Ethics (2010): 178-85
• Fisher & Syed, "Global Justice in Health Care" (2007)

 

 

Version 1.2

Last modified: January 27, 2015